 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Nanoscopic Probes Can Track Down And Attack Cancer Cells
West Lafayette IN (SPX) Apr 03, 2009 A researcher has developed probes that can help pinpoint the location of tumors and might one day be able to directly attack cancer cells. Joseph Irudayaraj, a Purdue University associate professor of agricultural and biological engineering, developed the nanoscale, multifunctional probes, which have antibodies on board, to search out and attach to cancer cells. A paper detailing the technology was released last week in the online version of Angewandte Chemie, an international chemistry journal. "If we have a tumor, these probes should have the ability to latch on to it," Irudayaraj said. "The probe could carry drugs to target, treat as well as reveal cancer cells." Scientists have developed probes that use gold nanorods or magnetic particles, but Irudayaraj's nanoprobes use both, making them easier to track with different imaging devices as they move toward cancer cells. The magnetic particles can be traced through the use of an MRI machine, while the gold nanorods are luminescent and can be traced through microscopy, a more sensitive and precise process. Irudayaraj said an MRI is less precise than optical luminescence in tracking the probes, but has the advantage of being able to track them deeper in tissue, expanding the probes' possible applications. The probes, which are about 1,000 times smaller than the diameter of a human hair, contain the antibody Herceptin, used in treatment of metastatic breast cancer. The probes would be injected into the body through a saline buffering fluid, and the Herceptin would find and attach to protein markers on the surface of cancer cells. "When the cancer cell expresses a protein marker that is complementary to Herceptin, then it binds to that marker," Irudayaraj said. "We are advancing the technology to add other drugs that can be delivered by the probes." Irudayaraj said better tracking of the nanoprobes could allow doctors to pinpoint the location of known tumors and better treat the cancer. The novel probes were tested in cultured cancer cells. Irudayaraj said the next step would be to run a series of tests in mice models to determine the dose and stability of the probes. The research was funded through a National Institute of Health grant, as well as by the Purdue Research Foundation. Irudayaraj is head of a biological engineering team that includes postdoctoral researcher Chungang Wang and graduate student Jiji Chen. Share This Article With Planet Earth
Related Links Purdue University Hospital and Medical News at InternDaily.com
Intel, GE team up on home health care technology
Washington (AFP) April 2, 2009US computer chip-maker Intel Corp. and industrial giant General Electric on Thursday announced plans to team up in home health technology, a sector expected to see rapid growth in coming years. |
|
|
| The content herein, unless otherwise known to be public domain, are Copyright 1995-2007 - SpaceDaily.AFP and UPI Wire Stories are copyright Agence France-Presse and United Press International. ESA Portal Reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement,agreement or approval of any opinions, statements or information provided by SpaceDaily on any Web page published or hosted by SpaceDaily. Privacy Statement |
del.icio.us
Digg
Reddit
YahooMyWeb
Google
Facebook